Trials / Completed
CompletedNCT00730756
A Pilot Study In Adults And Adolescents With Irritant (Non-Allergic) Rhinitis
A Pilot, Randomised, Double-blind, Placebo-controlled, Parallel-group, Multicentre Study to Evaluate the Efficacy and Safety of Once-daily Intranasal Administration of Fluticasone Furoate Nasal Spray 110 mcg for 4 Weeks in Adults and Adolescents With Irritant (Non-Allergic) Rhinitis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 102 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this pilot study is to compare the effects (effectiveness and safety)of an intranasal corticosteroid (fluticasone furoate nasal spray \[FFNS\]) with a placebo nasal spray for the treatment of irritant (non-allergic) rhinitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fluticasone Furoate Nasal Spray | Fluticasone furoate nasal spray 110mcg intranasally once daily for 4 weeks |
| OTHER | Placebo Nasal Spray | Matching placebo nasal spray intranasally once daily for 4 weeks |
Timeline
- Start date
- 2008-03-01
- Primary completion
- 2009-02-01
- Completion
- 2009-02-01
- First posted
- 2008-08-08
- Last updated
- 2017-04-06
- Results posted
- 2009-11-25
Locations
5 sites across 1 country: Thailand
Source: ClinicalTrials.gov record NCT00730756. Inclusion in this directory is not an endorsement.